Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816044.RAdQWkOFG8-eykdb4Giw2N5vj861ZbVK5xMJ990Xzatl8130_provenance.
• assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP919949.RAZfIm5CoFEMn8GviM_vF4z6u5OEjCuolJ-iTOXz_Txbs130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919949.RAZfIm5CoFEMn8GviM_vF4z6u5OEjCuolJ-iTOXz_Txbs130_provenance.
• NP919952.RARkXVnMGaHAk5rKDufwC2864fO2DsQM9Y-SyyQwSc8Pg130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919952.RARkXVnMGaHAk5rKDufwC2864fO2DsQM9Y-SyyQwSc8Pg130_provenance.
• NP815987.RAhDRaJihXoZQB--eTImYpTWm2sOiVLewHdG7rvlGgSvY130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815987.RAhDRaJihXoZQB--eTImYpTWm2sOiVLewHdG7rvlGgSvY130_provenance.
• NP816055.RAv-vc2zbSfIsmFU0DomxNHhvvYk3WN9NPNBbZWKzK-kE130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816055.RAv-vc2zbSfIsmFU0DomxNHhvvYk3WN9NPNBbZWKzK-kE130_provenance.
• NP919953.RAs-1N8jq423U4yiACJy5n-lTS_W-6uouoF9hEjD0LJio130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919953.RAs-1N8jq423U4yiACJy5n-lTS_W-6uouoF9hEjD0LJio130_provenance.
• NP587385.RAIlYmqnzMzap6MkA_Wc1yBTbHGxXBc7SYXeKIwrtNkV4130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587385.RAIlYmqnzMzap6MkA_Wc1yBTbHGxXBc7SYXeKIwrtNkV4130_provenance.
• NP587473.RA9TKa2yk-PJOAgIlDxqaq2bL4AqbDwG3MoNlKYkNnN_Q130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587473.RA9TKa2yk-PJOAgIlDxqaq2bL4AqbDwG3MoNlKYkNnN_Q130_provenance.
• NP587484.RA1kJByxGAwQg8bU12EiX1CpBIH3Y9VgWopZdcpr9AfjM130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587484.RA1kJByxGAwQg8bU12EiX1CpBIH3Y9VgWopZdcpr9AfjM130_provenance.
• NP919954.RAMojkMIvIl_a3XGIOq1Kt5xBwYP7kv23BnzSwsNUFq4w130_assertion description "[Our results show that Her2/neu targeting using Ad-based vectors for prostate cancer is feasible and may serve as a basis for the development of gene therapy of human prostate cancer as well as other Her2/neu-expressing cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919954.RAMojkMIvIl_a3XGIOq1Kt5xBwYP7kv23BnzSwsNUFq4w130_provenance.